2025
SJR Q1
JCR Q1 · 4,6
OA
1 matched articles
ESCI
Journal detail
Neuro-Oncology Advances
- Publisher
- Oxford University Press
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
26322498
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,421
- Quartile Q1
- H-Index 42
- Cites/doc 4,02
- Docs (3y) 551
- Cites (3y) 2.238
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 4,6
- 5Y JIF 4,4
- JCI 0,98
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Neurology (clinical) Q1
- Oncology Q1
- Surgery Q1
Areas
- Medicine
WoS categories
- Oncology | Clinical Neurology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,421 | 4,6 | 4,4 | 0,98 | Q2 | 42 |
| 2024 | Q1 | Q1 | 1,472 | 4,1 | 4,3 | 1,02 | Q1 | 33 |
| 2023 | Q1 | Q1 | 1,315 | 3,7 | 3,9 | 0,76 | Q2 | 33 |
| 2022 | Q1 | — | 1,052 | 3,5 | 3,6 | 0,59 | Q3 | 33 |
| 2021 | — | — | — | — | — | — | — | 33 |
| 2020 | — | — | — | — | — | — | — | 33 |
| 2019 | — | — | — | — | — | — | — | 33 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CLINICAL NEUROLOGY | ESCI | Q1 | Q2 | 48/296 |
| 2025 | ONCOLOGY | ESCI | Q2 | Q2 | 101/333 |
| 2024 | CLINICAL NEUROLOGY | ESCI | Q1 | Q2 | 51/286 |
| 2024 | ONCOLOGY | ESCI | Q2 | Q1 | 91/328 |
| 2023 | CLINICAL NEUROLOGY | ESCI | Q1 | Q2 | 63/280 |
| 2023 | ONCOLOGY | ESCI | Q2 | Q2 | 104/322 |
| 2022 | CLINICAL NEUROLOGY | ESCI | — | Q3 | — |
| 2022 | ONCOLOGY | ESCI | — | Q3 | — |